Aurinia Pharmaceuticals (AUPH) Cash & Equivalents (2016 - 2026)
Aurinia Pharmaceuticals' Cash & Equivalents was $179.83 million in Q2 2026, up 239.3% from $53 million a year earlier and up 338.5% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Aurinia Pharmaceuticals came in at $80.21 million, down 3.9% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -21.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $83.43 million in FY2024 (+70.7%), $48.88 million in FY2023 (-48.1%), $94.17 million in FY2022 (-59.4%) and $231.9 million in FY2021 (-14.9%).
- The Q2 2026 figure marks the highest quarterly Cash & Equivalents since Q4 2021.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 50.8%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q2 2026 (growth of 239.3%); the worst was Q4 2022 (a decline of 59.4%).
- Per Business Quant data, AUPH's Cash & Equivalents in the three quarters before Q2 2026 was $41.01 million (Q1 2026), $80.21 million (Q4 2025) and $73.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Aurinia Pharmaceuticals | 2.12 Bn | 548.16 Mn | 76.67 Mn | 179.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179.83 Mn |
| Mar 31, 2026 | 41.01 Mn |
| Dec 31, 2025 | 80.21 Mn |
| Sep 30, 2025 | 73.19 Mn |
| Jun 30, 2025 | 53.00 Mn |
| Mar 31, 2025 | 66.43 Mn |
| Dec 31, 2024 | 83.43 Mn |
| Sep 30, 2024 | 37.14 Mn |
| Jun 30, 2024 | 33.41 Mn |
| Mar 31, 2024 | 64.46 Mn |
| Dec 31, 2023 | 48.88 Mn |
| Sep 30, 2023 | 46.40 Mn |
| Jun 30, 2023 | 81.71 Mn |
| Mar 31, 2023 | 89.00 Mn |
| Dec 31, 2022 | 94.17 Mn |
| Sep 30, 2022 | 86.05 Mn |
| Jun 30, 2022 | 151.63 Mn |
| Mar 31, 2022 | 132.54 Mn |
| Dec 31, 2021 | 231.90 Mn |
| Sep 30, 2021 | 57.59 Mn |
API Access
Aurinia Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();